Vaxcyte, Inc. (PCVX) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
06:19 am
Sale
2021-12-3113GVAXCYTE INC
PCVX
Roche Finance Ltd2,334,113
4.400%
-253,641decrease
(-9.80%)
Filing
History
2022-02-10
5:24 pm
Purchase
2021-12-3113GVAXCYTE INC
PCVX
Janus Henderson Group Ltd.
JHG
4,246,664
8.000%
49,886increase
(+1.19%)
Filing
History
2022-02-10
08:42 am
Purchase
2021-12-3113GVAXCYTE INC
PCVX
VANGUARD GROUP INC3,134,286
5.940%
3,134,286increase
(New Position)
Filing
History
2022-02-09
10:01 am
Purchase
2022-02-0813GVAXCYTE INC
PCVX
FMR LLC7,874,350
14.917%
231,945increase
(+3.03%)
Filing
History
2022-02-04
4:12 pm
Purchase
2021-12-3113GVAXCYTE INC
PCVX
BlackRock Inc.
BLK
2,777,047
5.300%
2,777,047increase
(New Position)
Filing
History
2022-01-18
5:22 pm
Purchase
2021-12-3113GVAXCYTE INC
PCVX
TPG GP A, LLC4,149,544
7.900%
4,149,544increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2